Glaxo's Alli Favored For OTC Weight-Loss Use By FDA Joint Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 11-3 in favor of making Xenical available over the counter.